(Q37798007)

23 August 2017

title

Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine (English)

1 reference

23 August 2017

0 references

3

Gregory A Poland

1 reference

23 August 2017

2

Robert Jacobson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20923264

28 July 2024

author name string

Seth J. Sullivan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20923264

28 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20923264

28 July 2024

publication date

1 October 2010

1 reference

full work available at URL

23 August 2017

http://www.future-drugs.com/doi/abs/10.1586/erv.10.117

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20923264

http://www.tandfonline.com/doi/pdf/10.1586/erv.10.117

28 July 2024

1 reference

Expert Review of Vaccines

28 July 2024

published in

1 reference

23 August 2017

volume

9

1 reference

23 August 2017

issue

10

1 reference

23 August 2017

page(s)

1127-1133

1 reference

Mortality associated with influenza and respiratory syncytial virus in the United States

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Influenza-associated hospitalizations in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

The annual impact of seasonal influenza in the US: Measuring disease burden and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Antibody response to influenza vaccination in the elderly: a quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Antibody quantity versus quality after influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Immunosenescence: role and measurement in influenza vaccine response among the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Human innate immunosenescence: causes and consequences for immunity in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Efficacy and effectiveness of influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Evidence of bias in estimates of influenza vaccine effectiveness in seniors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Mortality benefits of influenza vaccination in elderly people: an ongoing controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Influenza virus resistance to antiviral agents: a plea for rational use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Safety of High Doses of Influenza Vaccine and Effect on Antibody Responses in Elderly Persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Pharmacology, vaccinomics, and the second golden age of vaccinology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Influenza- and RSV-associated hospitalizations among adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Emerging vaccines for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.117

Determinants of immunity to influenza infection in man

21 January 2018

7

1 reference

Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly

28 July 2024

10

1 reference

The Journal of Nutrition, Health and Aging

28 July 2024

17

8

9

Burns

2004

1 reference

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

28 July 2024

23

1 reference

Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly

28 July 2024

37

1 reference

Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents

28 July 2024

38

1 reference

28 July 2024

Identifiers

DOI

10.1586/ERV.10.117

1 reference

23 August 2017

1 reference